Acute Promyelocytic Leukemia: A Clinical Guide
Editat de Oussama Abla, Francesco Lo Coco, Miguel A. Sanzen Limba Engleză Paperback – feb 2019
Written by top experts in the field, Acute Promyelocytic Leukemia: A Clinical Guide is a valuable resource for clinicians and researchers who treat and investigate this disease in children and adults.
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (1) | 784.75 lei 38-44 zile | |
Springer International Publishing – feb 2019 | 784.75 lei 38-44 zile | |
Hardback (1) | 682.05 lei 38-44 zile | |
Springer International Publishing – 11 mai 2018 | 682.05 lei 38-44 zile |
Preț: 784.75 lei
Preț vechi: 826.06 lei
-5% Nou
Puncte Express: 1177
Preț estimativ în valută:
150.19€ • 158.42$ • 125.52£
150.19€ • 158.42$ • 125.52£
Carte tipărită la comandă
Livrare economică 27 decembrie 24 - 02 ianuarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9783030097134
ISBN-10: 3030097137
Pagini: 274
Ilustrații: XII, 274 p. 39 illus., 29 illus. in color.
Dimensiuni: 178 x 254 mm
Greutate: 0.59 kg
Ediția:Softcover reprint of the original 1st ed. 2018
Editura: Springer International Publishing
Colecția Springer
Locul publicării:Cham, Switzerland
ISBN-10: 3030097137
Pagini: 274
Ilustrații: XII, 274 p. 39 illus., 29 illus. in color.
Dimensiuni: 178 x 254 mm
Greutate: 0.59 kg
Ediția:Softcover reprint of the original 1st ed. 2018
Editura: Springer International Publishing
Colecția Springer
Locul publicării:Cham, Switzerland
Cuprins
History of APL.- Molecular Targets of Treatment in APL.- The Leukemic Stem Cell.- The Molecular Genetics of APL.- APL Coagulopathy.- Early Death in APL.- Prognostic Factors in APL.- First-line therapy for APL: Chemotherapy-based approach.- First-line Therapy: ATRA-ATO/Reduced Chemotherapy Approach.- Cure of APL without Chemotherapy.- Minimal Residual Disease in APL.- Treatment of refractory and relapsed APL.- Hematopoietic Stem Cell Transplantation in APL.- APL in Children.- Management of APL in the Elderly.- Special Situations in APL.- APL in Developing Countries: A Chemotherapy-Based Approach.- APL in Developing Countries: ATO based Approach.- Therapy-Related APL.- Rare Acute Leukemia Variants involving Retinoic Acid Receptor Genes.- Management of Treatment-Related Complications in APL.
Recenzii
“This is a clinical guide to acute promyelocytic leukemia or APL, and it is the first book dedicated entirely to APL. Starting with an engaging historical account, the book provides a comprehensive overview of the clinical and basic aspects of APL, once regarded as the most fatal type of acute myeloid leukemia, but now considered the most curable. … general practitioners and trainees also will find this book worth exploring … .” (Ravi Salgia, Doody's Book Reviews, January 04, 2019)
Notă biografică
Oussama Abla, MD
The Hospital for Sick Children and University of Toronto
Division of Hematology/Oncology
Toronto, ON
Canada
Francesco Lo-Coco, MD
Professor of Hematology
University of Tor Vergata Rome
Italy
Miguel A. Sanz, MD
Centro de Investigación Biomédica en Red de Cáncer
Madrid
Spain
The Hospital for Sick Children and University of Toronto
Division of Hematology/Oncology
Toronto, ON
Canada
Francesco Lo-Coco, MD
Professor of Hematology
University of Tor Vergata Rome
Italy
Miguel A. Sanz, MD
Centro de Investigación Biomédica en Red de Cáncer
Madrid
Spain
Textul de pe ultima copertă
This book provides a comprehensive overview on the clinical issues and biology of acute promyelocytic leukemia (APL) and on the molecular mechanisms of targeted therapy with ATRA and ATO. The text covers major topics such as the pathophysiology of APL coagulopathy, biologic and clinical differences between children and adults with APL, and the role of minimal residual disease monitoring. Additionally, the book summarizes historical, current, and future treatment strategies in both adults and children, while highlighting the most recent therapeutic recommendations for relapsed disease and the evolving indications for autologous and allogeneic stem cell transplant. This volume also features chapters focusing on secondary APL and therapy, late effects, rare presentations such as APL in the elderly and during pregnancy, and rare APL variants that may represent therapeutic challenges.
Written by top experts in the field, Acute Promyelocytic Leukemia: A Clinical Guide is a valuable resource for clinicians and researchers who treat and investigate this disease in children and adults.
Written by top experts in the field, Acute Promyelocytic Leukemia: A Clinical Guide is a valuable resource for clinicians and researchers who treat and investigate this disease in children and adults.
Caracteristici
First comprehensive text on acute promyelocytic leukemia in the last ten years Summarizes historical, current, and future treatment strategies Highlights the most recent therapeutic recommendations for relapsed disease Written by top experts in the field